rs6326
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002506.3(NGF):c.-12-1033G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0775 in 152,200 control chromosomes in the GnomAD database, including 1,524 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.077 ( 1524 hom., cov: 32)
Consequence
NGF
NM_002506.3 intron
NM_002506.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.558
Publications
3 publications found
Genes affected
NGF (HGNC:7808): (nerve growth factor) This gene is a member of the NGF-beta family and encodes a secreted protein which homodimerizes and is incorporated into a larger complex. This protein has nerve growth stimulating activity and the complex is involved in the regulation of growth and the differentiation of sympathetic and certain sensory neurons. Mutations in this gene have been associated with hereditary sensory and autonomic neuropathy, type 5 (HSAN5), and dysregulation of this gene's expression is associated with allergic rhinitis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.266 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NGF | NM_002506.3 | c.-12-1033G>C | intron_variant | Intron 2 of 2 | ENST00000369512.3 | NP_002497.2 | ||
| NGF | NM_001437545.1 | c.-12-1033G>C | intron_variant | Intron 1 of 1 | NP_001424474.1 | |||
| NGF-AS1 | NR_157569.1 | n.207+4600C>G | intron_variant | Intron 1 of 1 | ||||
| NGF | XM_011541518.3 | c.154-1033G>C | intron_variant | Intron 2 of 2 | XP_011539820.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0773 AC: 11758AN: 152084Hom.: 1518 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
11758
AN:
152084
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0775 AC: 11791AN: 152200Hom.: 1524 Cov.: 32 AF XY: 0.0735 AC XY: 5470AN XY: 74424 show subpopulations
GnomAD4 genome
AF:
AC:
11791
AN:
152200
Hom.:
Cov.:
32
AF XY:
AC XY:
5470
AN XY:
74424
show subpopulations
African (AFR)
AF:
AC:
11200
AN:
41472
American (AMR)
AF:
AC:
416
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5174
South Asian (SAS)
AF:
AC:
7
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
6
AN:
292
European-Non Finnish (NFE)
AF:
AC:
48
AN:
68018
Other (OTH)
AF:
AC:
114
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
442
884
1327
1769
2211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
68
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.